Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
16 hedge funds and large institutions have $826K invested in Novo Integrated Sciences, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
95% more capital invested
Capital invested by funds: $424K → $826K (+$402K)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
14% more funds holding
Funds holding: 14 → 16 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66.2K |
| 2 |
Jane Street
New York
|
+$59.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$19.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.6K |
| 5 |
VF
Virtu Financial
New York
|
+$9.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$16.2K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.78K |
| 4 |
BlackRock
New York
|
-$941 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$59 |
NVOS Hedge Fund Activity: Q2 2024 in Review
16 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q2 2024, worth a combined $826K — up 95% from $424K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NVOS positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $66.2K. The largest seller was XTX Topco, cutting an estimated $16.2K.
- 16 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q2 2024, up from 14 in Q1 2024.
- Funds reported $826K of Novo Integrated Sciences, Inc. Common Stock stock for Q2 2024, up 95% quarter-over-quarter.
- 4 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q2 2024 and 2 closed out, a net change of +2 holders.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q2 2024 was Vanguard Group, an estimated $66.2K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q2 2024 was XTX Topco, an estimated $16.2K sold.
Based on aggregated 13F filings for Q2 2024.